Spanish Oncology Genito-urinary Group
Clinical trials sponsored by Spanish Oncology Genito-urinary Group, explained in plain language.
-
New drug combo aims to shrink bladder tumors before surgery
Disease control Recruiting nowThis study tests a drug called erdafitinib, alone or with another drug (cetrelimab), given before surgery to people with muscle-invasive bladder cancer whose tumors have certain gene changes (FGFR). The goal is to see if these drugs can shrink or eliminate the cancer before the b…
Phase: PHASE2 • Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Disease control
Last updated May 17, 2026 08:03 UTC
-
Real-World check: do new cancer drugs deliver outside clinical trials?
Knowledge-focused Recruiting nowThis study looks at how effective newly approved drugs for genitourinary cancers (like kidney, bladder, or prostate cancer) are when used in routine medical practice. Researchers will collect data from 500 patients across Spain to see if the drugs work as well in real life as the…
Sponsor: Spanish Oncology Genito-Urinary Group • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC